Design Principles of Bioresorbable Polymeric Scaffolds

Area of Science:

• Biomaterials Science
• Cardiovascular Medicine
• Medical Devices

Background:

• Percutaneous coronary intervention (PCI) has evolved through balloon angioplasty, bare metallic stents, and drug-eluting stents.
• Each previous generation of PCI devices had limitations that bioresorbable vascular scaffolds (BVS) aim to overcome.
• BVS represent a significant advancement by combining the therapeutic advantages of prior technologies into a single, absorbable device.

Purpose of the Study:

• To introduce the concept and operational principles of bioresorbable vascular scaffolds (BVS).
• To highlight the phased functionality of BVS, aligning with physiological needs over time.
• To explain the material science basis for BVS degradation, focusing on aliphatic polyesters.

Main Methods:

• The study conceptualizes BVS by integrating features from balloon angioplasty, bare metallic stents, and drug-eluting stents.
• It outlines a three-phase operational principle: revascularization, restoration, and resorption.
• The degradation mechanism is based on the hydrolytic breakdown of aliphatic polyesters, exemplified by poly(l-lactide).

Main Results:

• BVS are designed to provide mechanical support and deliver therapeutic agents, similar to current stents.
• The scaffold material undergoes controlled degradation, with progressive decreases in molecular weight, strength, and mass.
• This degradation occurs in three distinct stages, matching the evolving physiological requirements post-implantation.

Conclusions:

• Bioresorbable vascular scaffolds offer a promising new approach in cardiovascular intervention.
• Their phased functionality and controlled resorption address the limitations of permanent metallic stents.
• The use of hydrolytically degradable polyesters like poly(l-lactide) is key to achieving the desired in vivo performance profile.